Zobrazeno 1 - 10
of 3 664
pro vyhledávání: '"pathological response"'
Autor:
Shuqiang Liu, Cong Jiang, Danping Wu, Shiyuan Zhang, Kun Qiao, Xiaotian Yang, Boqian Yu, Yuanxi Huang
Publikováno v:
BMC Women's Health, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Achieving a pathological complete response (pCR) after neoadjuvant therapy (NAT) is considered to be a critical factor for a favourable prognosis in breast cancer. However, discordant pathological complete response (DpCR), charact
Externí odkaz:
https://doaj.org/article/755f9300443b4033b681abe3db6db6c1
Publikováno v:
Annals of Oncology Research and Therapy, Vol 4, Iss 2, Pp 31-37 (2024)
BACKGROUND: Neoadjuvant chemotherapy therapy ( NACT) has emerged as an integrated therapeutic approach to treat locally advanced breast cancer in order to down stage the tumour and to assess tumour response to chemotherapy. The aims of this study wer
Externí odkaz:
https://doaj.org/article/6d858d7a310a4fe2bb4b7c79648b48bf
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-14 (2024)
Abstract Neoadjuvant chemotherapy (NACT) is a viable therapeutic option for women diagnosed locally advanced cervical cancer (LACC). However, the factors influencing pathological response are still controversial. We collected pair specimens of 185 LA
Externí odkaz:
https://doaj.org/article/7d42ffb1e5be4272a9d8c2908507b15c
Autor:
Neree Payan, Benoit Presles, Charles Coutant, Isabelle Desmoulins, Sylvain Ladoire, Françoise Beltjens, François Brunotte, Jean-Marc Vrigneaud, Alexandre Cochet
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Background: The aim of this study is to investigate the added value of combining tumour blood flow (BF) and metabolism parameters, including texture features, with clinical parameters to predict, at baseline, the pathological complete respon
Externí odkaz:
https://doaj.org/article/c9ec157b39b2468e84ff3d4667dfdc97
Autor:
Joanna Streb, Agnieszka Łazarczyk, Przemysław Hałubiec, Anna Streb-Smoleń, Julita Ciuruś, Magdalena Ulatowska-Białas, Martyna Trzeszcz, Kamil Konopka, Diana Hodorowicz-Zaniewska, Joanna Szpor
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundBreast cancer (BC) is the most commonly diagnosed malignant tumor in women. The disease and its subsequent treatment pose a serious burden on the quality of life of patients. Neoadjuvant chemotherapy (NAC) has become one of the crucial stra
Externí odkaz:
https://doaj.org/article/02f1f982252d422c9c54ec420f2e956f
Autor:
Dan Han, Hao Li, Xin Zheng, Shenbo Fu, Ran Wei, Qian Zhao, Chengxin Liu, Zhongtang Wang, Wei Huang, Shaoyu Hao
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectiveDevelop a predictive model utilizing weakly supervised deep learning techniques to accurately forecast major pathological response (MPR) in patients with resectable non-small cell lung cancer (NSCLC) undergoing neoadjuvant chemoimmunotherapy
Externí odkaz:
https://doaj.org/article/3f657eb1dca74a938e52617a1ee4caa7
Autor:
Misbah Younus Soomro, Saqib Raza Khan, Hafiz Muhammad, Sujjawal Ahmad, Nawazish Zehra, Insia Ali, Mirza Rameez Samar, Arif Hameed, Munira Moosajee, Yasmin Abdul Rashid
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Rectal cancer treatment has transformed in recent years, with neoadjuvant treatment (NT) and total neoadjuvant treatment (TNT) aiming to enhance pathological responses. This pioneering study in our country delves into rectal cance
Externí odkaz:
https://doaj.org/article/3c7022d9963247c9a66fef97fa4bb276
Autor:
Gang Ji, Qi Yang, Song Wang, Xiaolong Yan, Qiuxiang Ou, Li Gong, Jinbo Zhao, Yongan Zhou, Feng Tian, Jie Lei, Xiaorong Mu, Jian Wang, Tao Wang, Xiaoping Wang, Jianyong Sun, Jipeng Zhang, Chenghui Jia, Tao Jiang, Ming-gao Zhao, Qiang Lu
Publikováno v:
Genome Medicine, Vol 16, Iss 1, Pp 1-19 (2024)
Abstract Background The efficacy of neoadjuvant chemo-immunotherapy (NAT) in esophageal squamous cell carcinoma (ESCC) is challenged by the intricate interplay within the tumor microenvironment (TME). Unveiling the immune landscape of ESCC in the con
Externí odkaz:
https://doaj.org/article/c62f320d7e1543318917e757b10ff962
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundPatients with resectable esophageal squamous cell carcinoma (ESCC) receiving neoadjuvant immunotherapy (NIT) display variable treatment responses. The purpose of this study is to establish and validate a radiomics based on enhanced computed
Externí odkaz:
https://doaj.org/article/addbf022cb784cad87c93ea6bd71bead